Healio

Direct-to-consumer testing may help identify alpha-1 antitrypsin deficiency

Please provide your email address to receive an email when new articles are posted on . Direct-to-consumer testing, combined with clinical follow-up, helped identify patients with undiagnosed alpha-1 ...

How Investors Are Reacting To Beam Therapeutics (BEAM) ARK’s Renewed Bet On Base-Editing Biotech

In recent days, Cathie Wood’s ARK Invest has materially increased its holdings in Beam Therapeutics, adding more than 195,000 ...
The Globe and Mail

Alpha-1 Antitrypsin Deficiency Treatment Market 2034: Clinical Trials, EMA, PDMA, FDA Approvals, Medication, and Companies by DelveInsight

Alpha-1 Antitrypsin Deficiency Companies are Kamada Pharmaceuticals, Arrowhead Pharmaceuticals, Takeda, Mereo BioPharma, AstraZeneca, Inhibrx, Novo Nordisk, and others. (Albany, USA) DelveInsight's ...
WUKY

UK Healthcare earns designation as a resource center for alpha-1 antitrypsin deficiency

Alpha-1 antitrypsin deficiency (AATD) leaves lungs vulnerable to damage. Dr. Malik Khurram Khan, who leads UK's advanced COPD ...
technologynetworks

Making Alpha-1-Antitrypsin in the Lab Will Save on Donor Blood

Alpha-1-antitrypsin is a protein produced by the liver. The protein gets secreted to the blood stream, where it circulates the body to protect the lungs. However, some people are born with genetic ...
Medindia

Alpha-1 Antitrypsin Deficiency

Alpha-1 antitrypsin deficiency is an inherited disorder that mostly affects the lung and liver. The condition occurs all over the world but its incidence differs according to regions and population.
Max Planck Society

Alpha-1 antitrypsin deficiency: What protects the one – and not the other?

Alpha-1-antitrypsin is a so-called protease inhibitor, a type of enzyme inhibitor. It is produced in the liver but exerts its effects in the lungs, where it regulates immune cell activity. This ...
Healio

Intravenous alpha-1 antitrypsin improves survival in patients with deficiency

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Augmentation therapy increased survival in patients with ...
Business Wire

Dicerna Announces Interim Results From Phase 1 Trial of Belcesiran for Treatment of Alpha-1 Antitrypsin Deficiency-Associated Liver Disease

LEXINGTON, Mass.--(BUSINESS WIRE)--Dicerna Pharmaceuticals, Inc. (Nasdaq: DRNA) (the “Company” or “Dicerna”), a leading developer of investigational ribonucleic acid interference (RNAi) therapeutics, ...
Healthline

Liver Disease from Alpha-1 Antitrypsin Deficiency

Alpha-1 antitrypsin deficiency (AATD) is an inherited genetic disorder. It can occur in anyone but is more common in people with ancestry in North and Central Europe. People with AATD experience ...
News Medical

What is Alpha-1 Antitrypsin Deficiency?

Alpha-1 antitrypsin deficiency (AATD) is a genetic disease wherein the individual has a greater risk of developing chronic obstructive pulmonary disease (COPD), liver disease, and skin problems such ...